🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/03/2017 | 60,36 | 60,72 | 60,35 | 60,63 | +0,14% | 0,60% | 7.979.472 |
| 30/03/2017 | 60,59 | 60,76 | 60,42 | 60,54 | -0,30% | 0,57% | 5.577.456 |
| 29/03/2017 | 60,75 | 61,17 | 60,55 | 60,73 | +0,47% | 1,02% | 8.525.794 |
| 28/03/2017 | 60,31 | 60,50 | 60,00 | 60,44 | +0,24% | 0,82% | 10.673.880 |
| 27/03/2017 | 60,04 | 60,51 | 59,93 | 60,30 | +0,02% | 0,95% | 8.400.663 |
| 24/03/2017 | 60,27 | 60,62 | 59,98 | 60,29 | -0,16% | 1,06% | 9.575.052 |
| 23/03/2017 | 60,46 | 60,90 | 60,30 | 60,38 | -0,35% | 0,99% | 9.915.128 |
| 22/03/2017 | 61,05 | 61,17 | 60,35 | 60,59 | -0,64% | 1,34% | 10.007.352 |
| 21/03/2017 | 61,37 | 61,65 | 60,71 | 60,98 | -0,31% | 1,54% | 11.057.134 |
| 20/03/2017 | 61,20 | 61,36 | 61,07 | 61,17 | +0,33% | 0,47% | 13.593.818 |
| 17/03/2017 | 61,31 | 61,74 | 60,96 | 60,97 | -0,44% | 1,26% | 15.142.762 |
| 16/03/2017 | 61,61 | 61,82 | 61,06 | 61,24 | -0,80% | 1,24% | 10.074.634 |
| 15/03/2017 | 61,45 | 61,99 | 61,28 | 61,74 | +0,78% | 1,16% | 9.458.200 |
| 14/03/2017 | 61,19 | 61,56 | 61,12 | 61,26 | +0,08% | 0,72% | 8.271.759 |
| 13/03/2017 | 62,25 | 62,30 | 61,08 | 61,21 | -2,21% | 1,96% | 14.880.133 |
| 10/03/2017 | 63,04 | 63,17 | 62,50 | 62,60 | -0,44% | 1,06% | 9.247.447 |
| 09/03/2017 | 62,95 | 63,01 | 62,52 | 62,87 | +0,14% | 0,77% | 8.106.280 |
| 08/03/2017 | 62,94 | 63,09 | 62,28 | 62,79 | -0,24% | 1,29% | 8.821.645 |
| 07/03/2017 | 62,43 | 63,27 | 62,20 | 62,94 | -0,77% | 1,71% | 8.728.478 |
| 06/03/2017 | 63,05 | 63,72 | 62,88 | 63,43 | -0,17% | 1,33% | 9.104.500 |
| 03/03/2017 | 63,05 | 63,57 | 62,80 | 63,53 | +0,76% | 1,23% | 8.716.111 |
| 02/03/2017 | 63,34 | 63,53 | 62,98 | 63,05 | -0,20% | 0,87% | 9.062.790 |
| 01/03/2017 | 63,04 | 63,74 | 62,87 | 63,18 | +0,52% | 1,38% | 11.193.374 |
| 28/02/2017 | 62,80 | 63,12 | 62,64 | 62,85 | +0,03% | 0,76% | 8.112.044 |
| 27/02/2017 | 62,77 | 62,92 | 62,56 | 62,83 | -0,47% | 0,58% | 7.476.222 |
| 24/02/2017 | 62,64 | 63,13 | 62,62 | 63,13 | +0,47% | 0,81% | 8.849.626 |
| 23/02/2017 | 62,52 | 63,08 | 62,36 | 62,83 | +0,86% | 1,16% | 7.184.669 |
| 22/02/2017 | 62,50 | 62,74 | 62,11 | 62,30 | -0,29% | 1,01% | 9.096.221 |
| 21/02/2017 | 61,93 | 62,77 | 61,93 | 62,48 | +0,14% | 1,36% | 7.740.633 |
| 17/02/2017 | 62,21 | 62,56 | 61,89 | 62,40 | +0,20% | 1,07% | 9.482.618 |